Close
Nordic 9Nordic 9

En Pointe LLC (investor - Others)

United States
See something wrong or missing? Let us know
Offices:San Francisco

En Pointe is an American investment company associated with San Francisco based large family offices, led by David Lamond, and which invests through a variety of entities, in private companies at all stages of growth across healthcare, technology, real estate and consumer industries.

Average round investment:14.43M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: France EG 427
Mostly invests in: France France (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to En Pointe LLC

Name Criteria
France Alter Equity
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Vives Fund
66%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Essential Investments
66%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium VIB
66%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium V-Bio Ventures
66%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Agri Investment Fund
66%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy AurorA Science
66%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Jaquet Partners
66%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium Gemma Frisius Fund
66%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Singapore Clay Capital
66%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top